Assembly Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Net Income	-61.23	-93.09	-129.86	-62.15	-97.63	-90.75	-42.81	-44.26	-28.45	-23.79	Upgrade
Depreciation & Amortization	0.45	0.5	0.47	0.69	0.49	0.64	0.22	0.08	0.06	0.01	Upgrade
Share-Based Compensation	5.12	6.59	5.24	21.85	20.56	28.49	8.6	5.02	7.88	10.64	Upgrade
Other Operating Activities	78.4	1.54	30.76	-23.35	-7.49	-3.34	35.85	4.28	1.81	-1.83	Upgrade
Operating Cash Flow	22.74	-84.46	-93.4	-62.96	-84.07	-64.96	1.86	-34.88	-18.7	-14.97	Upgrade
Capital Expenditures	-0.23	-0.1	-2.24	-0.47	-1.55	-0.34	-0.87	-0.15	-0.06	-0.15	Upgrade
Acquisitions	0	1.5	1.5	-1.75	0	0	0	0	0	0.51	Upgrade
Change in Investments	-68.91	89.24	27.25	70.29	-48.76	-135.06	-14.78	36.34	-64.8	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	-0.08	Upgrade
Investing Cash Flow	-69.14	90.64	26.52	68.07	-50.32	-135.4	-15.64	36.2	-64.86	0.28	Upgrade
Share Issuance / Repurchase	13.82	0.61	53.06	7.6	139.65	159.79	67.24	0.15	81.57	16.73	Upgrade
Financing Cash Flow	13.82	0.61	53.06	7.6	139.65	159.79	67.24	0.15	81.57	16.73	Upgrade
Net Cash Flow	-32.58	6.79	-13.82	12.71	5.26	-40.56	53.46	1.47	-1.98	2.03	Upgrade
Free Cash Flow	22.51	-84.57	-95.64	-63.43	-85.62	-65.3	1	-35.03	-18.76	-15.12	Upgrade
Free Cash Flow Margin	-	-	-1529.18%	-80.18%	-536.37%	-441.08%	11.03%	-	-	-	Upgrade
Free Cash Flow Per Share	4.92	-20.96	-26.52	-21.48	-39.13	-34.37	0.67	-24.40	-14.33	-25.93	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).